CDKN2A and melanoma: Concerning the particularities encountered in patients with CDKN2A mutations, a study by Taylor et al., investigating the role of the aforementioned genetic alteration on the types and numbers of nevi detected in melanoma-prone families and sporadic cases, found that CDKN2A mutation carriers exhibited a generally greater prevalence of atypical nevi than CDKN2A-wild type patients [11].